CNS infections in patients with hematological or oncological diseases (including cellular therapies) – 2024 update of the guideline of the Infectious Diseases Working Party (AGIHO) of the German Socie... Infections of the central nervous system (CNS) occur in up to 15% of patients with hematological or oncological diseases (HOD), particularly in high-r…

CNS infections in hematology/oncology: the 2024 AGIHO/DGHO guideline update is out now. Key insights on rapid diagnostics, tailored therapy & emerging options. Read more: www.sciencedirect.com/science/arti...

#CNSinfections #Hematology #Oncology #AGIHO #DGHO @jannikstemler.bsky.social

2024 update of the AGIHO guideline on diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients with solid tumours and hematological malignancies Febrile Neutropenia is an emergency in the treatment of cancer patients. It requires prompt and evidence-based clinical and antimicrobial management. …

🚨 #FebrileNeutropenia =medical emergency in #cancer care! Prompt, evidence-based management=key to reducing morbidity&mortality. #AGIHO #DGHO guideline with risk stratification, diagnostics & treatment recommendations. #hematology #Oncology #InfectiousDiseases
www.sciencedirect.com/science/arti...